One of the largest India-based Discovery, Development and Manufacturing solutions provider to the Biopharma industry will be there at CPhI Worldwide 2017, Germany. Leave your details here to connect: http://bit.ly/2x7ekf6
Our scientists have a strong background in drug discovery and in-depth knowledge in disease biology. Our experience in validating rodent models and screening compounds have led to further IND studies for our clients. Know more about us: http://bit.ly/2uSVHhW
Our capabilities range from small molecule synthesis, library synthesis, peptide synthesis and nucleotide and nucleoside & nucleotide synthesis, while our logistics team ensures quick turnaround time. Staying true to our prime objective, we deliver valuable scientific solutions with speed and quality. Learn more about us: http://bit.ly/2tvIXO9
According to statistics published by the WHO, approximately 8.2 million deaths are recorded each year from cancer, which accounts for 13.0% deaths worldwide. The increasing incidence of cancer, and high failure rate of existing treatment options is propelling the growth of Contract Research Organization (CRO) oncology services.
GVK BIO, one of the largest India-based Discovery, Development and Manufacturing solutions provider to the Biopharma industry will be giving a VR demo of its discovery facilities at #BIO2017. Drop by at our booth.
The global pharmaceutical outsourcing market was estimated to be $113.7 billion in 2016. Know more on Dr.Subir Basak, Chief Business Officer, GVK Biosciences take on trends in Drug Discovery Outsourcing: https://lnkd.in/f28TTG4
We are looking forward to be a part of #BIO2017 - the world’s largest gathering of the biotechnology industry. We will also be giving a VR demo of our discovery facilities. Do drop by to witness our labs in VR!
We want to set benchmarks in Contract Manufacturing solutions we provide, which is why we have regulatory and statutory approvals to attest our standards. Know more about us at #BIO2017. Do leave your details here to schedule a meeting: http://bit.ly/2rY2DYC
GVK BIO is set mark its presence at #BIO2017. Don’t forget to visit us at Booth No. 949. You can choose to schedule a meeting with us using the BIO One-one-one Partnering Portal here: https://lnkd.in/fHiZ-9V
The world’s largest and most important gathering of global biotechnology leaders is coming together to celebrate the ‘breakthrough’ innovations that have put the biotechnology industry at the forefront. GVK BIO is excited to attend the BIO International Convention 2017.
There are so many ways natural systems support our own prosperity and well-being. Let's take a step towards preserving the natural ecosystem by planting a tree on World Environment Day. Spread the word!
International Day of Action for Women's Health marks the importance of denouncing any attempts made at curtailing women's rights, their sexualities and lives - free from coercion, discrimination and violence.
InformEx is a marketplace designed to bring key business leaders together in order to foster dynamic business relationships and we are going to be a part of that. Fill in your details to connect with us: http://bit.ly/2qfZelo
We will be in the company of chemistry specialists at InformEx from 16th to 18th May 2017. InformEx is a marketplace designed to bring key business leaders together in order to foster dynamic business relationships.
GVK BIO is set to mark its presence at InformEx in the Pennsylvania Convention Center from 16th to 18th May 2017. Looking forward to connect with prospective partners in the chemical discovery and commercialization industry
We are happy to announce our participation in the 2017 BIO International Convention in Korea - the next generation growth engine for the future of the bio industry. Know more about us: https://www.gvkbio.com/
We extend a warm welcome to Sreehari P Babu who has joined us as Vice President - Formulations and Analytical Services. He has 18+ years of experience in pharmaceutical development with more than 12 years in a leadership role. Prior to joining us, he has worked in organisations like Dr. Reddy's Laboratories, Novartis Pharmaceuticals and Ranbaxy Research Laboratories.
GVK BIO is delighted to have Brian Shaughnessy as the Sr. Vice President, Sales and Marketing, Discovery and Development. Brian has more than 20 years of experience as a sales leader with a demonstrated track record of high performing business results in organisations like Piramal and Dr. Reddy's Laboratories.
Girinandan Valluri, General Manger – Corporate Services was awarded for his Thought Leadership Excellence in General Administration by Indian Association of Facility Management & Square Roof. Thank you for the outstanding work!
Dr. Subir Basak brings strong leadership and track record in Biotech & Pharma and Healthcare, having built several businesses and turned around loss making units back to profitability and sustainable growth in the sector. He has held increasing levels of responsibility at Merck, Amgen and Bayer in US, and Dr. Reddy's and Jubilant in India. He holds an MBA from Kellogg School of Management and MS/PhD from Purdue University and BE from IIT.
We are happy to announce our latest accolade that was bestowed upon us by Asia’s biggest event “Manufacturing Supply Chain Summit 2017”. Mr. Anand Kamat, Senior Vice President & Head–Supply Chain Management received the Winner Award for GVK Biosciences Private Limited at the recently held 6th Annual Summit in Mumbai. The winners are selected by eminent Jury members; holding CEO/CXO positions; from various Manufacturing & Service industries in India.
If you are looking to combine your forte in business with a passion for life sciences, we are exactly what you are looking for. A keen eye for business (experience of about 6-10 years) with preferably a background in sciences is what we hope for. For more information, check out -https://lnkd.in/f6PbMfM
Join our CEO, Mr. Manni Kantipudi at the Make In India Panel Discussion at BioAsia 2017 as he speaks about the Power of Manufacturing Clusters. Expect a great exchange of ideas from the best in the industry, and do visit us at Booth #4 and 5. See you there! To learn more, visit us at gvkbio.com
Head to India's largest biotech industry event this year, a vibrant global platform for the convergence of thought-leaders, ideas and innovation: BioAsia 2017. Visit us at Booth #4 and 5. To learn more, visit us at gvkbio.com
Researchers at the School of Science at Indiana University-Purdue University Indianapolis have developed and tested a new molecular binding technique that could shorten or abridge the human and animal drug discovery and development process. The new method is also potentially more economical and ecologically friendly than what is currently used.
The 21st Century Cures Act, which aims at speeding FDA approval for drugs and medical devices will allow the agency to include "real world evidence" in the approval process. Drug companies will be able to submit drug data summaries, instead of the clinical trials that are a much longer process. Watch the video to know more about "Real World Evidence" and its impact on the Drug approval process.
The U.S. House of Representatives voted to pass the 21st Century Cures Act, which will likely be voted on by members of the U.S. Senate in early December. The act’s purpose is to accelerate the discovery, development and delivery of new medicines. Media reports indicate that the bill would set in motion a $6.3 billion initiative in an effort to not only fund research in development in many medical fields but also increase consumer access to various treatments. What are your thoughts?
The launch of a new 8,000 sq ft GMP Compliant Analytical Services Laboratory is a continuation of our strategy to be a leading provider of R&D services to the Life Sciences industry. We are expanding our analytical capabilities to support a wide array of high-quality research, aimed at further servicing our global clients.